Policymakers Prep for “Cures 2.0”

January 7, 2020

Reps. Diana DeGette and Fred Upton, who authored the 21st Century Cures Act in 2016, announced last year their intention to update the bill in 2020.

Breakthrough Cystic Fibrosis Treatment on the Horizon

June 7, 2019

Elated. Nervous. Hopeful. That’s how thousands of cystic fibrosis patients felt upon hearing last week’s news: the Food and Drug Administration will soon review a new triple combination therapy that could drastically improve their quality of life.

New “Fast Facts” Scrutinizes ICER

April 9, 2019

Policymakers, providers and patients all feel the impact of The Institute for Clinical and Economic Review, whose ubiquitous cost-effectiveness reports can determine patients’ access to medicine.

FDA Hearing Explores Competition & Innovation in Biosimilars

September 7, 2018

When it comes to how to increase the development and utilization of biosimilars, the Food and Drug Administration is all ears.  On Tuesday, the agency welcomed numerous physicians and experts to testify on competition and innovation in the biosimilars marketplace.  And at least one physician identified a critical component in uptake: physician confidence.

The Crossroads of Clinical Trials and Social Media

July 3, 2018

What can America learn at the crossroads of social media and clinical trials? At a recent National Institutes of Health workshop, one organization had a clear answer: powerful methods for heightening clinical trials awareness.